[go: up one dir, main page]

DK0644746T3 - Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse - Google Patents

Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse

Info

Publication number
DK0644746T3
DK0644746T3 DK93913793T DK93913793T DK0644746T3 DK 0644746 T3 DK0644746 T3 DK 0644746T3 DK 93913793 T DK93913793 T DK 93913793T DK 93913793 T DK93913793 T DK 93913793T DK 0644746 T3 DK0644746 T3 DK 0644746T3
Authority
DK
Denmark
Prior art keywords
drug
moderate
application
delivery
transdermal
Prior art date
Application number
DK93913793T
Other languages
English (en)
Inventor
Werner E Heiber
Charles D Ebert
Dinesh C Patel
Srinivasan Venkateshwaran
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of DK0644746T3 publication Critical patent/DK0644746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93913793T 1992-06-11 1993-05-03 Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse DK0644746T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89726992A 1992-06-11 1992-06-11
PCT/US1993/004152 WO1993025168A1 (en) 1992-06-11 1993-05-03 The use of glycerin in moderating transdermal drug delivery

Publications (1)

Publication Number Publication Date
DK0644746T3 true DK0644746T3 (da) 1999-12-20

Family

ID=25407656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93913793T DK0644746T3 (da) 1992-06-11 1993-05-03 Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse

Country Status (13)

Country Link
EP (1) EP0644746B1 (da)
JP (1) JPH08501529A (da)
KR (1) KR950701508A (da)
AT (1) ATE184473T1 (da)
AU (1) AU677206B2 (da)
CA (1) CA2135925C (da)
DE (1) DE69326461T2 (da)
DK (1) DK0644746T3 (da)
ES (1) ES2137993T3 (da)
GR (1) GR3031246T3 (da)
HU (1) HU221598B (da)
NZ (1) NZ253409A (da)
WO (1) WO1993025168A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE69630918T2 (de) 1995-06-09 2004-10-28 Hisamitsu Pharmaceutical Co., Inc., Tosu Matrix für Iontophorese
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
AU747041B2 (en) * 1997-11-10 2002-05-09 Strakan International Limited Penetration enhancing and irritation reducing systems
DE10019311A1 (de) * 2000-04-19 2001-10-31 Lohmann Therapie Syst Lts Transdermale therapuetische Systeme zur Applikation von Moxonidin
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
EP1315502B1 (en) * 2000-08-30 2010-03-17 Unimed Pharmaceuticals, LLC Method for treating erectile dysfunction and increasing libido in men
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
JP2006505583A (ja) 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7879357B2 (en) 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
BRPI0611134A2 (pt) 2005-06-03 2010-08-17 Acrux Dds Pty Ltd método e composição para liberação transdérmica de fármaco
US8147815B2 (en) 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
IN2009KN02397A (da) 2007-01-11 2015-08-07 Acrux Dds Pty Ltd
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
FR2924942B1 (fr) * 2007-12-14 2012-06-15 Pf Medicament Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
HUE028121T2 (en) * 2009-06-12 2016-11-28 Cynapsus Therapeutics Inc Sublingual apomorphine
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
KR102161392B1 (ko) 2010-12-16 2020-10-05 선오비온 파마슈티컬스 인코포레이티드 설하 필름
TWI576111B (zh) * 2011-02-25 2017-04-01 久光製藥股份有限公司 用於經皮或經黏膜投予之佐劑及含有該佐劑之醫藥製劑
EP3064218B1 (en) 2013-10-31 2019-06-19 Hisamitsu Pharmaceutical Co., Inc. Adjuvant composition
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
PT3285771T (pt) 2015-04-21 2025-03-31 Sunovion Pharmaceuticals Inc Métodos de tratamento da doença de parkinson pela administração de apomorfina a uma mucosa oral
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS6272611A (ja) * 1985-09-27 1987-04-03 Kao Corp 皮膚外用剤
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
GB9016056D0 (en) * 1990-07-21 1990-09-05 Chatfield Pharmaceuticals Limi Transdermal medicine delivery devices
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
WO1993010163A2 (en) * 1991-11-12 1993-05-27 Nepera, Inc. Adhesive hydrogels having extended use lives and process for the preparation of same

Also Published As

Publication number Publication date
AU677206B2 (en) 1997-04-17
DE69326461D1 (de) 1999-10-21
GR3031246T3 (en) 1999-12-31
EP0644746A1 (en) 1995-03-29
NZ253409A (en) 1996-09-25
EP0644746B1 (en) 1999-09-15
ATE184473T1 (de) 1999-10-15
ES2137993T3 (es) 2000-01-01
KR950701508A (ko) 1995-04-28
DE69326461T2 (de) 2000-05-04
HU9403555D0 (en) 1995-02-28
AU4369493A (en) 1994-01-04
HU221598B (hu) 2002-11-28
CA2135925A1 (en) 1993-12-23
WO1993025168A1 (en) 1993-12-23
HUT71521A (en) 1995-12-28
CA2135925C (en) 2001-04-10
EP0644746A4 (en) 1995-09-13
JPH08501529A (ja) 1996-02-20

Similar Documents

Publication Publication Date Title
DK0644746T3 (da) Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse
Smith et al. Percutaneous penetration enhancers
US5614211A (en) Oxybutynin transdermal device having decreased delamination
US5238933A (en) Skin permeation enhancer compositions
CA2517493C (en) Therapeutic patch with polysiloxane matrix comprising capsaicin
EP0922453A3 (en) Percutaneous absorption type preparation containing tulobuterol
US20050187212A1 (en) Pharmaceutical composition for topical delivery of meloxicam
BR9713492A (pt) ésteres de ácido graxo de ácido glicólico e seus sais como realçadores de permeação
GR1001025B (el) Μεθοδος δια διαδερμικην (υποδοριον παροχην ibuprofen, δια χρησιμοποιησεως υδραλκοολικου πυκτωματος (γελης).
DE3277453D1 (en) Use of eucalyptol for enhancing skin permeation of bioaffecting agents
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
DE122012000021I1 (de) Hautpenetrationsforderer sowie diese verwendende.
DK0957900T3 (da) Sammensætninger og fremgangsmåder til topisk påföring af terapeutiske midler
WO1998037872A3 (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EP0251464A3 (en) Composition for the control of insects
KR850700218A (ko) 약학 조성물
ITMI990834A1 (it) Cerotto per uso topico eparina e diclofenac
GB1453167A (en) Skin protective gel
ES2074030A1 (es) Composiciones portadoras, autocalentadoras y aplicables en terapeutica por via topica.
PT1229909E (pt) Entrega transdermica de lasofoxifeno
JPH03505835A (ja) 経皮ドラッグデリバリーシステム
CA2096963C (en) A two-phase topical composition
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
US4834980A (en) Transdermal delivery of azatidine
JPH0365323B2 (da)